Financhill
Buy
67

HCC Quote, Financials, Valuation and Earnings

Last price:
$89.25
Seasonality move :
4.38%
Day range:
$88.38 - $89.90
52-week range:
$38.00 - $89.90
Dividend yield:
0.36%
P/E ratio:
133.53x
P/S ratio:
3.83x
P/B ratio:
2.21x
Volume:
218.8K
Avg. volume:
753.7K
1-year change:
64.14%
Market cap:
$4.7B
Revenue:
$1.5B
EPS (TTM):
$0.67

Earnings Data

Next earnings date for HCC
Feb 18
2026
Most recent earnings per share
$0.70
Beat by $1.21
(Nov 5/2025)
Consensus Estimate
-$0.51
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

HCC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/18/2026 Q4 $382.2M -- -- $0.68 --
11/05/2025 Q3 $300M $327.9M $0.70 -$0.51 $1.21
08/06/2025 Q2 $285.6M $298.8M $0.11 -$0.36 $0.47
04/30/2025 Q1 $284.6M $298.2M -$0.16 -$0.23 $0.07
02/13/2025 Q4 $306.7M $297.5M $0.02 $0.46 -$0.43
10/30/2024 Q3 $324M $327.7M $0.80 $0.63 $0.16
08/01/2024 Q2 $389.9M $396.5M $1.35 $1.30 $0.06
05/01/2024 Q1 $476.6M $503.5M $2.62 $2.56 $0.06
02/14/2024 Q4 $394.6M $365M $2.47 $2.64 -$0.16
11/01/2023 Q3 $366.9M $423.5M $1.64 $1.71 -$0.07
08/02/2023 Q2 -- $379.7M $1.58 -- --
05/03/2023 Q1 -- $509.7M $3.51 -- --
02/15/2023 Q4 -- $344.8M $1.93 -- --
11/02/2022 Q3 -- $390.2M $1.90 -- --
08/03/2022 Q2 -- $625.2M $5.74 -- --
05/05/2022 Q1 -- $378.7M $2.83 -- --
02/22/2022 Q4 -- $415.5M $2.69 -- --
11/02/2021 Q3 -- $202.5M $0.74 -- --
08/04/2021 Q2 -- $227.4M -$0.09 -- --
05/05/2021 Q1 -- $213.8M -$0.42 -- --
02/24/2021 Q4 -- $212.3M -$0.66 -- --
10/28/2020 Q3 -- $180.1M -$0.28 -- --
08/05/2020 Q2 -- $163.7M -$0.18 -- --
04/29/2020 Q1 -- $226.7M $0.42 -- --
02/19/2020 Q4 -- $204.9M $0.41 -- --
10/30/2019 Q3 -- $287.5M $0.87 -- --
07/31/2019 Q2 -- $397.6M $2.43 -- --
05/01/2019 Q1 -- $378.3M $2.14 -- --
02/21/2019 Q4 -- $360.4M $7.11 -- --
10/31/2018 Q3 -- $273.3M $1.00 -- --
08/01/2018 Q2 -- $322.6M $1.72 -- --
05/02/2018 Q1 -- $421.8M $3.36 -- --
02/14/2018 Q4 -- $239.8M $1.83 -- --
11/09/2017 Q3 -- $312M $2.27 -- --
08/03/2017 Q2 -- $363.4M $2.46 -- --
03/31/2017 Q1 -- $254M $2.06 -- --
12/31/2016 Q4 -- -- $0.64 -- --
09/30/2016 Q3 -- -- -$0.64 -- --
06/30/2016 Q2 -- -- -$0.95 -- --
03/31/2016 Q1 -- -- -$1.17 -- --

Warrior Met Coal, Inc. Earnings Questions

  • How Much did Warrior Met Coal, Inc. Generate in Revenue Last Quarter?

    Warrior Met Coal, Inc. reported $327.9M worth of top line sales in its most recent quarter.

  • Did Warrior Met Coal, Inc. Beat Earnings Last Quarter?

    Warrior Met Coal, Inc. announced earnings per share of $0.70 which represents a beat of analyst forecast a -$0.51 per share.

  • Is Warrior Met Coal, Inc. Profitable?

    Warrior Met Coal, Inc. reported $37.2M that represents $0.71 per share over the last quarter.

  • What is the Analyst Consensus for Warrior Met Coal, Inc. EPS Next Year?

    Warrior Met Coal, Inc.'s earnings are forecast to decrease from $4.79 per share to $5.21 per share next year representing a decrease of -72.23%.

  • When is Warrior Met Coal, Inc.'s Earnings Date?

    Warrior Met Coal, Inc.'s next earnings date is February 18, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock